Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
Despite advances in pharmacotherapy, intervention devices and techniques, residual cardiovascular risks still cause a large burden on public health. Whilst most guidelines encourage achieving target levels of specific lipids and lipoproteins to reduce these risks, increasing evidence has shown that...
Main Authors: | Chih-Kuo Lee, Che-Wei Liao, Shih-Wei Meng, Wei-Kai Wu, Jiun-Yang Chiang, Ming-Shiang Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/8/985 |
Similar Items
-
Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients[S]
by: Johanna Apro, et al.
Published: (2015-08-01) -
Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01) -
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01) -
A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice
by: Yosuke Ando, et al.
Published: (2003-06-01) -
Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis
by: Michael S. Yee, et al.
Published: (2008-06-01)